EUVIMEDEUVIMED entdecken
Crossref

Clinical and Radiological Heterogeneity in Anti‐Neurofascin‐155 Autoimmune Nodopathy: A Case Series Analysis

Michie Imamura, Hironori Mizutani iD, Keiichi Nakahara, Hidenori Ogata, Tomoaki Taguchi, Masao Imura, Toshiya Nomura, Yohei Misumi, Noriko Isobe iD, Mitsuharu Ueda iD

Journal of the Peripheral Nervous System · 2025

DOI: 10.1111/jns.70077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Peripheral Nervous System, 2025. Verfasst von Michie Imamura und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan. Hauptthemen laut MEDLINE: Cell Adhesion Molecules, Autoantibodies, Nerve Growth Factors, Autoimmune Diseases of the Nervous System. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Autoimmune nodopathy with anti‐neurofascin‐155 (NF155) antibodies is increasingly recognized as a distinct disease entity. Although these patients have been described, not all aspects have been fully elucidated. We investigated clinical phenotypes, biomarker profiles, and treatment outcomes in patients with anti‐NF155 antibody‐positive autoimmune nodopathy.

Methods

We retrospectively analyzed seven Japanese patients (aged 13–27 years) with anti‐NF155 antibody‐positive autoimmune nodopathy treated at Kumamoto University Hospital between 2017 and 2020. Clinical, electrophysiological, radiological, and biomarker data were evaluated. One refractory case was followed up for over 80 months, tracking serum neurofilament light chain (sNfL) and anti‐NF155 antibody levels in the serum and cerebrospinal fluid (CSF).

Results

All patients exhibited severe sensory ataxia and motor dysfunction. Trigeminal nerve hypertrophy was observed in five individuals, without corresponding symptoms, and pes cavus in one patient. All patients demonstrated a pronounced demyelinating neuropathy phenotype. The mean CSF protein level was 343 mg/dL. Intravenous immunoglobulin (IVIg) had minimal efficacy, while corticosteroids produced good responses in four patients and partial responses in three patients. Rituximab markedly improved a refractory case. Anti‐NF155 antibody and sNfL levels correlated with clinical status. Magnetic resonance imaging frequently revealed persistent nerve root hypertrophy despite functional improvement.

Interpretation

Anti‐NF155 nodopathy is a distinct, biomarker‐trackable entity; corticosteroids and rituximab outperform IVIg, challenging conventional practice and highlighting the need for antibody testing, especially in young patients with severe demyelinating neuropathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell Adhesion MoleculesAutoantibodiesNerve Growth FactorsAutoimmune Diseases of the Nervous SystemHumansAdultFemaleYoung AdultRetrospective StudiesMaleAdolescentBiomarkersNeurofilament Proteins

Stichwörter der Autor:innen

anti‐neurofascin‐155 antibodiesautoimmune nodopathyneurofilament light chainrituximabtreatment response

Substanzen

NFASC protein, humanCell Adhesion MoleculesAutoantibodiesNerve Growth FactorsBiomarkersNeurofilament Proteins

Autor:innen und Institutionen

  • Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

ORCID-Profile: Hironori Mizutani, Noriko Isobe, Mitsuharu Ueda

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Imamura, M., Mizutani, H., Nakahara, K., Ogata, H., Taguchi, T., Imura, M., Nomura, T., Misumi, Y., Isobe, N., & Ueda, M. (2025). Clinical and Radiological Heterogeneity in Anti‐Neurofascin‐155 Autoimmune Nodopathy: A Case Series Analysis. Journal of the Peripheral Nervous System. https://doi.org/10.1111/jns.70077

Vancouver

Imamura M, Mizutani H, Nakahara K, Ogata H, Taguchi T, Imura M, et al. Clinical and Radiological Heterogeneity in Anti‐Neurofascin‐155 Autoimmune Nodopathy: A Case Series Analysis. Journal of the Peripheral Nervous System. 2025. doi:10.1111/jns.70077

BibTeX
@article{Imamura2025,
  author = {Imamura, Michie and Mizutani, Hironori and Nakahara, Keiichi and Ogata, Hidenori and Taguchi, Tomoaki and Imura, Masao and Nomura, Toshiya and Misumi, Yohei and Isobe, Noriko and Ueda, Mitsuharu},
  title = {Clinical and Radiological Heterogeneity in Anti‐Neurofascin‐155 Autoimmune Nodopathy: A Case Series Analysis},
  journal = {Journal of the Peripheral Nervous System},
  year = {2025},
  doi = {10.1111/jns.70077}
}
Kostenlos starten →